Davis Select International ETF (DINT)
- Previous Close
23.52 - Open
23.94 - Bid 23.88 x 800
- Ask 23.94 x 1000
- Day's Range
23.94 - 23.94 - 52 Week Range
16.75 - 25.74 - Volume
626 - Avg. Volume
9,350 - Net Assets 208.14M
- NAV 23.51
- PE Ratio (TTM) 14.30
- Yield 1.34%
- YTD Daily Total Return 26.91%
- Beta (5Y Monthly) 1.15
- Expense Ratio (net) 0.66%
The fund's investment adviser uses the Davis Investment Discipline to invest the fund's portfolio principally in common stocks (including indirect holdings of common stock through depositary receipts) issued by foreign companies, including countries with developed or emerging markets. The fund may invest in large, medium or small companies without regard to market capitalization.
Davis ETFs
Fund Family
Foreign Large Blend
Fund Category
208.14M
Net Assets
2018-03-01
Inception Date
Performance Overview: DINT
View MoreTrailing returns as of 10/15/2024. Category is Foreign Large Blend.
People Also Watch
Holdings: DINT
View MoreTop 10 Holdings (54.46% of Total Assets)
Sector Weightings
Related ETF News
View MoreResearch Reports: DINT
View MoreDaily – Vickers Top Buyers & Sellers for 11/17/2023
The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
Lowering target price to $18.00
ANIKA THERAPEUTICS INC has an Investment Rating of HOLD; a target price of $18.000000; an Industry Subrating of Medium; a Management Subrating of Low; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Low; and a Value Subrating of Medium.
RatingPrice TargetLowering target price to $21.00
ANIKA THERAPEUTICS INC has an Investment Rating of SELL; a target price of $21.000000; an Industry Subrating of Medium; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Low; a Growth Subrating of Medium; and a Value Subrating of Medium.
RatingPrice TargetLowering target price to $22.00
ANIKA THERAPEUTICS INC has an Investment Rating of SELL; a target price of $22.000000; an Industry Subrating of Medium; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Low; a Growth Subrating of Low; and a Value Subrating of Medium.
RatingPrice Target